You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study

Citation Tools

Article menu
Emerging technologies, pharmacology and therapeutics
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kudo A, Machii N, Ono T, et al
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study
BMJ Open Diabetes Research and Care 2023;11:e003302. doi: 10.1136/bmjdrc-2022-003302